Jiangsu GDK Biotechnology Co Ltd (688670) - Total Liabilities

Latest as of March 2026: CN¥279.22 Million CNY ≈ $40.86 Million USD

Based on the latest financial reports, Jiangsu GDK Biotechnology Co Ltd (688670) has total liabilities worth CN¥279.22 Million CNY (≈ $40.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jiangsu GDK Biotechnology Co Ltd (688670) asset resilience to evaluate the company's liquid asset resilience ratio.

Jiangsu GDK Biotechnology Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Jiangsu GDK Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Jiangsu GDK Biotechnology Co Ltd balance sheet assets.

Jiangsu GDK Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu GDK Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Beijing Seeyon Internet Software Cp SHG:688369	China	CN¥626.34 Million
Nordic Paper Holding AB ST:NPAPER	Sweden	Skr4.20 Billion
Career Technology MFG Co Ltd TW:6153	Taiwan	NT$6.91 Billion
Platinum Capital Ltd AU:PMC	Australia	AU$18.98 Million
InPlay Oil Corp TO:IPO	Canada	CA$795.00 Million
Dhani Services Limited NSE:DHANI	India	Rs-28.77 Billion
Century Therapeutics Inc NASDAQ:IPSC	USA	$54.66 Million
SMS Electric Co Ltd Zhengzhou SHE:002857	China	CN¥423.10 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Jiangsu GDK Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Jiangsu GDK Biotechnology Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu GDK Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu GDK Biotechnology Co Ltd (2017–2025)

The table below shows the annual total liabilities of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥319.50 Million ≈ $46.75 Million	+25.13%
2024-12-31	CN¥255.33 Million ≈ $37.36 Million	-1.99%
2023-12-31	CN¥260.52 Million ≈ $38.12 Million	-29.03%
2022-12-31	CN¥367.11 Million ≈ $53.72 Million	+25.24%
2021-12-31	CN¥293.12 Million ≈ $42.89 Million	-45.26%
2020-12-31	CN¥535.47 Million ≈ $78.36 Million	+5.89%
2019-12-31	CN¥505.68 Million ≈ $74.00 Million	+26.19%
2018-12-31	CN¥400.73 Million ≈ $58.64 Million	+11.50%
2017-12-31	CN¥359.39 Million ≈ $52.59 Million	--

About Jiangsu GDK Biotechnology Co Ltd

SHG:688670 China Biotechnology

Market Cap

$342.53 Million

CN¥2.34 Billion CNY

Market Cap Rank

#14348 Global

#4316 in China

Share Price

CN¥19.00

Change (1 day)

+2.43%

52-Week Range

CN¥12.97 - CN¥30.90

All Time High

CN¥75.07